Haymaker Acquisition Corp. III Merges with Biote
June 3, 2022
Haymaker Acquisition Corp. III, a publicly traded SPAC, completed its merger with consumer-directed hormone optimization company Biote (transaction announced Dec 13, 2021; closed May 27, 2022). Biote operates a platform that trains and certifies practitioners and provides practice management software, marketing support and branded nutraceutical products, and had grown a network of roughly 4,700 Biote-certified practitioners in the U.S.
- Buyers
- Haymaker Acquisition Corp. III
- Targets
- Biote
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
HTL Biotechnology Acquires Modern Meadow's Beauty & Biomedical Division
May 6, 2024
Biotechnology
HTL Biotechnology has acquired the beauty and biomedical division of American company Modern Meadow, including its recombinant proteins platform and leading human recombinant collagen type III (rhCOL3) technology. The deal expands HTL's biopolymer portfolio and R&D/manufacturing capabilities, strengthens its presence in North America, and accelerates development of cosmetic and medical-grade recombinant collagen products.
-
Equillium Acquires Bioniz Therapeutics
February 16, 2022
Biotechnology
Equillium, Inc. (Nasdaq: EQ) acquired privately held Bioniz Therapeutics, obtaining exclusive worldwide rights to Bioniz's pipeline (BNZ-1, BNZ-2, BNZ-3) and proprietary discovery platform in an all-stock transaction (5,699,492 shares, ~19.3% of Equillium outstanding) plus up to $57.5M in development milestones and up to $250M in sales milestones. The acquisition expands Equillium's immunology capabilities and pipeline, adding complementary clinical-stage cytokine-targeting assets and key research and clinical personnel.
-
INVO Bioscience Acquires NAYA Biosciences; Combined Company to Operate as NAYA Biosciences
October 14, 2024
Biotechnology
INVO Bioscience has completed a reverse-triangular merger to acquire 100% of NAYA Biosciences, and the combined company will operate as NAYA Biosciences (NASDAQ: NAYA). The combined business will continue INVO's revenue-generating fertility operations while adding NAYA's clinical-stage oncology and autoimmune therapeutics pipeline and updating management and board composition.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
Biobest Group Acquires BioWorks, Inc.
July 10, 2023
Agriculture
Biobest Group has completed its acquisition of BioWorks, Inc., a Victor, New York-based manufacturer and marketer of biopesticides. The deal expands Biobest's biopesticide portfolio and establishes BioWorks' Victor facility as the group's North American manufacturing and marketing hub for biopesticides.
-
EmergentMedTech Merges with TRU Biologix
January 22, 2025
Biotechnology
EmergentMedTech announced a merger with TRU Biologix to integrate TRU Biologix's Wharton's Jelly–derived cell and tissue biologics into EmergentMedTech's regenerative medicine and aesthetics product portfolio. The deal expands EmergentMedTech's capabilities alongside its role as the exclusive U.S. distributor of NeoGen PSR, enabling delivery of advanced biologics to hundreds of clinics and clinician partners.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.